Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) - Aix-Marseille Université Access content directly
Journal Articles Biology of Blood and Marrow Transplantation Year : 2020

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

J.R. Passweg
  • Function : Author
M. Labopin
  • Function : Author
M. Christopeit
  • Function : Author
J. Cornelissen
  • Function : Author
T. Pabst
  • Function : Author
G. Socié
  • Function : Author
N. Russel
  • Function : Author
I. Yakoub-Agha
T. Gedde-Dahl
  • Function : Author
H. Labussière-Wallet
  • Function : Author
R. Malladi
  • Function : Author
E. Forcade
  • Function : Author
S. Maury
E. Polge
  • Function : Author
F. Lanza
  • Function : Author
N.C. Gorin
  • Function : Author
M. Mohty
A. Nagler
  • Function : Author

Domains

Immunology

Dates and versions

hal-03152838 , version 1 (25-02-2021)

Identifiers

Cite

J.R. Passweg, M. Labopin, M. Christopeit, J. Cornelissen, T. Pabst, et al.. Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Biology of Blood and Marrow Transplantation, 2020, 26 (4), pp.659-664. ⟨10.1016/j.bbmt.2019.11.021⟩. ⟨hal-03152838⟩

Collections

CNRS UNIV-AMU CRCM
27 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More